Skip to content
Konrad Förstner edited this page Apr 5, 2020 · 7 revisions

Improving sharing of SARS-CoV-2 genomes

Currently the vast majority (>90%) of SARS-CoV-2 genomes are shared via GISAID. This platform was built to encourage the sharing of influenza genomes, and in this regard appears to have been successful. It uses a data usage agreement (DUA) and to allow researchers to share with the platform, and the platform to share with other researchers who have agreed to the DUA. Unfortunately, this requires manual curation of registrants, and prevents the development of derivative, open data products using the genomes in GISAID.

We will support the development of an open submission process that GISAID users can transition to.

Participants

Clone this wiki locally